OpenAlex
PricingAboutJobs
Log inGet started
Work

The efficacy and safety of memantine for the treatment of Alzheimer’s disease

HTML

Year: 2018
Type: article
Source: Expert Opinion on Drug Safety
DOI: 10.1080/14740338.2018.1524870
Authors: Shinji Matsunaga, Taro Kishi, Ikuo Nomura, Kenji Sakuma, Makoto Okuya, Toshikazu Ikuta, Nakao Iwata
Institutions: Fujita Health University, University of Mississippi
Language: English

Topic: Cholinesterase and Neurodegenerative Diseases
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: memantine, Alzheimer's disease, cholinesterase inhibitors, donepezil, galantamine, rivastigmine, combination therapy, cognitive function, behavioral problems, drug safety, adverse events, treatment discontinuation, risk-benefit assessment
SDG: Good health and well-being

Open Access status: closed

Funders: Daiichi-Sankyo, U.S. Food and Drug Administration
OpenAlex ID: W2889658841
FWCI: 4.558
Cites: 14
Cited by: 140
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security